Following this month's FDA approval of Eli Lilly’s amyloid-busting antibody Kisunla (donanemab), the Alzheimer’s disease ...
The dog days of summer might be in full swing, but for flu vaccine makers, its a busy time prepping for this fall's influenza ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results